We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+13.49%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
+$167M
Cap. Flow
+$24.1M
Cap. Flow %
1.76%
Top 10 Hldgs %
57.21%
Holding
359
New
25
Increased
120
Reduced
185
Closed
27

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$19.7M
2
PDD icon
Pinduoduo
PDD
+$16.1M
3
NIO icon
NIO
NIO
+$12.8M
4
MRVL icon
Marvell Technology
MRVL
+$11M
5
TSM icon
TSMC
TSM
+$10.1M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$23.6M
2
LEGN icon
Legend Biotech
LEGN
+$19.4M
3
TCOM icon
Trip.com Group
TCOM
+$15.4M
4
ZLAB icon
Zai Lab
ZLAB
+$8.54M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.3M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.1%
2 Technology 29.22%
3 Communication Services 14%
4 Healthcare 8.72%
5 Real Estate 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
151
Travere Therapeutics
TVTX
$5.33B
$417K 0.03%
18,532
+1,781
+11% +$37.9K
BMRN icon
152
BioMarin Pharmaceuticals
BMRN
$11.5B
$415K 0.03%
4,268
+137
+3% +$14.2K
RLAY icon
153
Relay Therapeutics
RLAY
$4.02B
$415K 0.03%
25,192
+512
+2% +$9.18K
BPMC
154
DELISTED
Blueprint Medicines
BPMC
$414K 0.03%
9,195
+267
+3% +$12K
TGTX icon
155
TG Therapeutics
TGTX
$8.58B
$413K 0.03%
27,428
-11,965
-30% -$182K
PCAR icon
156
PACCAR
PCAR
$69.6B
$412K 0.03%
5,627
-364
-6% -$26K
NVAX icon
157
Novavax
NVAX
$1.23B
$410K 0.03%
59,231
+33,630
+131% +$309K
ALKS icon
158
Alkermes
ALKS
$8.82B
$409K 0.03%
14,513
-2,603
-15% -$70.9K
APLS
159
DELISTED
Apellis Pharmaceuticals
APLS
$409K 0.03%
6,207
-2,397
-28% -$138K
DHR icon
160
Danaher
DHR
$135B
$409K 0.03%
1,830
-49
-3% -$11.1K
NBIX icon
161
Neurocrine Biosciences
NBIX
$17.7B
$408K 0.03%
4,031
+425
+12% +$44.2K
IONS icon
162
Ionis Pharmaceuticals
IONS
$9.35B
$406K 0.03%
11,372
+100
+0.9% +$3.75K
CRSP icon
163
CRISPR Therapeutics
CRSP
$4.58B
$404K 0.03%
8,936
+308
+4% +$15K
RVMD icon
164
Revolution Medicines
RVMD
$40.2B
$403K 0.03%
18,603
+6,162
+50% +$152K
NTLA icon
165
Intellia Therapeutics
NTLA
$1.5B
$402K 0.03%
10,782
-321
-3% -$12.6K
RARE icon
166
Ultragenyx Pharmaceutical
RARE
$2.65B
$400K 0.03%
9,964
-434
-4% -$18.6K
XEL icon
167
Xcel Energy
XEL
$51B
$399K 0.03%
5,917
-364
-6% -$24.6K
VIR icon
168
Vir Biotechnology
VIR
$1.47B
$397K 0.03%
17,081
+903
+6% +$23.1K
NTRA icon
169
Natera
NTRA
$37.5B
$396K 0.03%
7,135
-3,948
-36% -$189K
SAGE
170
DELISTED
Sage Therapeutics
SAGE
$395K 0.03%
9,412
+824
+10% +$35.4K
ROST icon
171
Ross Stores
ROST
$76.6B
$394K 0.03%
3,709
-260
-7% -$29.2K
ODFL icon
172
Old Dominion Freight Line
ODFL
$48.5B
$392K 0.03%
2,298
-166
-7% -$27.8K
KRTX
173
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$392K 0.03%
2,157
+14
+0.7% +$2.68K
PRTA icon
174
Prothena Corp
PRTA
$458M
$390K 0.03%
8,049
+806
+11% +$42.6K
BCRX icon
175
BioCryst Pharmaceuticals
BCRX
$2.37B
$389K 0.03%
46,585
+6,330
+16% +$60.9K
5 6
7
8 9

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, E Fund Management held 359 positions worth $1.37B, up 14% from $1.2B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q1 2023 filing shows 25 new, 120 increased, 185 reduced and 27 closed positions. Its largest new stake was Alibaba: 31,628 shares worth $3.23M. The largest sale was Qualcomm, an estimated $23.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 37% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q1 2023 buy was Alibaba: 31,628 shares worth $3.23M.
  • E Fund Management added most to Microsoft in Q1 2023, an estimated $19.7M increase.
  • E Fund Management's biggest Q1 2023 reduction was Qualcomm, cutting an estimated $23.6M.
  • E Fund Management fully exited United States Brent Oil Fund in Q1 2023, selling an estimated $1.75M.
  • E Fund Management's ten largest holdings make up 57% of its $1.37B portfolio in Q1 2023.
  • E Fund Management opened 25 new positions and closed 27 in Q1 2023.
  • E Fund Management's portfolio value rose 14% quarter-over-quarter to $1.37B.

Based on E Fund Management's 13F filing for Q1 2023, filed 11 May 2023.